Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Prospective, Observational, Multicenter Study on the Safety and Efficacy of Apixaban for the Prevention of Thromboembolism in Adults With Congenital Heart Disease and Atrial Arrhythmias: the PROTECT-AR Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03854149
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:06.706709+00:00
Published At
2023-06-22T00:00:00+00:00
Record Updated At
2023-06-22
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Congenital Heart Disease", "Atrial Arrhythmia", "Thromboembolism", "Anticoagulants Causing Adverse Effects in Therapeutic Use"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-06-22"
protocolSection.identificationModule.nctId
"NCT03854149"
protocolSection.identificationModule.officialTitle
"A Prospective, Observational, Multicenter Study on the Safety and Efficacy of Apixaban for the Prevention of Thromboembolism in Adults With Congenital Heart Disease and Atrial Arrhythmias: the PROTECT-AR Study"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Congenital Heart Disease (protocolSection.conditionsModule.conditions)
  • Atrial Arrhythmia (protocolSection.conditionsModule.conditions)
  • Thromboembolism (protocolSection.conditionsModule.conditions)
  • Anticoagulants Causing Adverse Effects in Therapeutic Use (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.